Table 1.
Baseline characteristics and TE results of all patients referred through the Nottingham liver disease stratification pathway
| Variable | Results N=968 |
|
| Male gender | n (%) | 470 (49) |
| Age (years) | Mean (SD) | 56.3 (13.7) |
| Body mass index (kg/m2) | Mean (SD) | 31.2 (6.9) |
| Current alcohol intake >14 units/week | n (%) | 304 (31.4) |
| Current smoker | n (%) | 276 (28.5) |
| Referral criteria | ||
| Harmful alcohol use only | n (%) | 94 (9.7) |
| AST:ALT ratio >0.8 only | n (%) | 357 (36.9) |
| NAFLD risk only | n (%) | 223 (23) |
| Combination | n (%) | 267 (27.6) |
| No criteria met | n (%) | 27 (2.8) |
| Bilirubin (μmol/L) | Mean (SD) | 12 (8) |
| AST (U/L) | Median (IQR) | 44 (28) |
| ALT (U/L) | Median (IQR) | 49 (28) |
| Albumin (g/L) | Mean (SD) | 42 (4) |
| Platelets (×109/L) | Mean (SD) | 265 (80) |
| FibroScan result | ||
| <8.0 kPa | n (%) | 740 (76.5) |
| 8.0–14.9 kPa | n (%) | 165 (17) |
| ≥15 kPa | n (%) | 57 (5.9) |
| Technical failure | n (%) | 6 (0.6) |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAFLD, non-alcoholic fatty liver disease; TE, transient elastography.